# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-21-046174
Filing Date
2021-04-02
Accepted
2021-04-02 17:26:42
Documents
5
Period of Report
2021-05-14

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | tm212332-1_def14a.htm | DEF 14A | 606647
2 | GRAPHIC | lg_innoviva-bw.jpg | GRAPHIC | 13063
3 | GRAPHIC | sg_pavelraifeld-bw.jpg | GRAPHIC | 14220
4 | GRAPHIC | tm212332d1-pc_noticebw.jpg | GRAPHIC | 439668
5 | GRAPHIC | tm212332d1-pc_votebw.jpg | GRAPHIC | 495642
| Complete submission text file | 0001104659-21-046174.txt |  | 1933988

Mailing Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010
Business Address 1350 OLD BAYSHORE HIGHWAY SUITE 400 BURLINGAME CA 94010 6502389600
Innoviva, Inc. (Filer) CIK: 0001080014 (see all company filings)

EIN.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-30319 | Film No.: 21803040
SIC: 2834 Pharmaceutical Preparations